| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Jan―16 |
Effectiveness of Vaccination in Preventing Coronavirus Disease 2019 Six Months or More After the Second Dose and Up to Five Months After the Third Dose in The Municipality of Voždovac (Belgrade, Serbia): A Real-Life Comparison of Four Vaccines |
|
| 2 |
[GO] |
2024―Sep―21 |
Alopecia Universalis after COVID-19 Vaccination: Case Report and Literature Review |
|
| 3 |
[GO] |
2024―Mai―18 |
COVID-19 Vaccine Breakthrough Infections and Compliance to Non-Pharmaceutical Public Health Interventions: A Nested Case-Control Study |
|
| 4 |
[GO] |
2024―Mai―13 |
COVID-19 Vaccination in South Asia-Challenges Faced, and Lessons Learnt |
|
| 5 |
[GO] |
2023―Jul―07 |
Lower Incidences and Deaths Due to COVID-19 in Countries with high Deaths Due to Tuberculosis and Flu: a 2021-2022 Update |
|
| 6 |
[GO] |
2023―Jul―07 |
Safety of SARS-CoV-2 Vaccines in Patients with Autoimmune Diseases |
|
| 7 |
[GO] |
2023―Mai―27 |
Prevention of Symptomatic Covid-19 Infection by Personal Dendritic Cell Vaccine |
|
| 8 |
[GO] |
2023―Mrz―22 |
New-onset Nephrotic Syndrome with Minimal Change Disease Following Pfizer-BioNTech COVID-19 Vaccine: A Case Report and Literature Review |
|
| 9 |
[GO] |
2022―Nov―26 |
Effect of Measles Immunity on the Prognosis of Acute COVID-19 Infection |
|
| 10 |
[GO] |
2021―Aug―20 |
Effectiveness of Post-Exposure Prophylaxis in Preventing Severe SARS-Cov2 Disease (PEP-VAX) |
|
| 11 |
[GO] |
2021―Apr―14 |
Saint James: Reflections on a Long Road of Treatments from Rheumatoid Arthritis to COVID-19 |
|
| 12 |
[GO] |
2020―Dez―15 |
Fall of the Rebel Angels: How SARS-Cov-2 Landed on Earth |
|
